Treatment of Relapsed or Refractory Natural Killer/T Cell Lymphoma

Clinical trial NCT03107962 · UNKNOWN

Trial details

NCT number: NCT03107962
Sponsor: Mingzhi Zhang
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Natural Killer/T-Cell Lymphoma, Nasal and Nasal-Type

Start date: 2017-02-19
Primary completion: 2018-12-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.